Search clinical trials for: Glucagon-like peptide-1 (GLP-1) receptor
Total 60064 results
-
University of BathArla FoodsCompletedGLP-1 ConcentrationUnited Kingdom
-
Instituto Nacional de Ciencias Medicas y Nutricion...CompletedGut Microbiota | GLP-1Mexico
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusJapan
-
Anders Fink-Jensen, MD, DMSciThe Novavì outpatient clinics, Copenhagen; Neurobiology Research Unit, Rigshospitalet... and other collaboratorsCompletedAddiction, Alcohol | Alcohol Dependence, in RemissionDenmark
-
Hvidovre University HospitalUnknown
-
University of ChicagoCompleted
-
Adrian VellaCompletedPancreatic Effects of 9,39-Exendin and 9,36-GLP-1United States
-
Rigshospitalet, DenmarkDepartment of Cardiovascular and Renal Research, University of Southern DenmarkCompleted
-
University of CopenhagenCopenhagen University Hospital, HvidovreRecruiting
-
Herlev HospitalUniversity of Copenhagen; The Danish Medical Research Council; The Danish Diabetes...Completed
-
Ludwig-Maximilians - University of MunichGerman Research Foundation; Merck Sharp & Dohme LLCCompletedHyperglycemiaGermany
-
Hospital for Special Surgery, New YorkRecruitingGlucagon-like Peptide 1 | Gastric Ultrasound | Point of Care UltrasoundUnited States, Canada
-
Eli Lilly and CompanyRecruiting
-
The University of Texas Health Science Center at...RecruitingPost-bariatric SurgeryUnited States
-
University of Missouri-ColumbiaAmerican Society for Metabolic and Bariatric SurgeryRecruitingHypertension | Diabetes Mellitus | Metabolic Syndrome | Morbid Obesity | Obstructive Sleep Apnea of AdultUnited States
-
National Health Research Institutes, TaiwanCompletedDiabetes Mellitus, Type 2Taiwan
-
University Hospital, Basel, SwitzerlandCompletedSmoking Cessation | Craving | Weight Change, Body | Glucagon-like Peptide-1Switzerland
-
University of Rome Tor VergataMerck Sharp & Dohme LLCCompletedMetabolic SyndromeItaly
-
Eli Lilly and CompanyActive, not recruitingGlucose Metabolism Disorders | Diabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Type2 Diabetes | Metabolic Disease | T2DM (Type 2 Diabetes Mellitus) | T2DUnited States, India, Australia, United Kingdom, Mexico, Brazil, Israel, France, Italy
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico, Australia, United Kingdom, Mexico, Argentina, Brazil, Israel, Canada
-
Danish Headache CenterUnknownHeadache, MigraineDenmark
-
Peking Union Medical College HospitalUnknownPolycystic Ovary SyndromeChina
-
Johns Hopkins UniversityMerck Sharp & Dohme LLCTerminatedGlucose HomeostasisUnited States
-
University Hospital, Gentofte, CopenhagenUniversity of CopenhagenUnknown
-
Eli Lilly and CompanyRegeneron PharmaceuticalsRecruitingObesityUnited States, Mexico
-
AstraZenecaTerminatedNon-alcoholic SteatohepatitisGermany
-
The Affiliated Hospital of Xuzhou Medical UniversityRecruitingType 2 Diabetes MellitusChina
-
Psychiatric Centre RigshospitaletNeurobiology Research UnitRecruitingAlcohol Dependence | Alcohol Use Disorder | Alcohol Abuse | Alcohol AddictionDenmark
-
Hangzhou Sciwind Biosciences Co., Ltd.Active, not recruitingType 2 Diabetes Mellitus | T2DMChina
-
Ludwig-Maximilians - University of MunichGerman Research Foundation; Philipps University Marburg Medical CenterCompletedDigestive Physiology | Gastrointestinal Motility | Gastrointestinal Hormones | Glucagon-like Peptide 1 | Exendin (9-39)Germany
-
University Hospital, Gentofte, CopenhagenUniversity of CopenhagenUnknown
-
Hangzhou Sciwind Biosciences Co., Ltd.Active, not recruitingType 2 Diabetes Mellitus | T2DMChina
-
Filip Krag KnopUniversity of CopenhagenCompletedTo Assess the Impact of Bile Acids on Human Glukagon-like-peptide-1 SecretionDenmark
-
University of Maryland, BaltimoreActive, not recruiting
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico, Spain, Germany, Argentina, Brazil, Turkey, Hungary, Italy, Russian Federation, Slovakia, Belgium, Czechia, Greece, Mexico, Romania
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Japan, India, Puerto Rico, Mexico
-
Michael A. NauckCompletedType 2 DiabetesGermany
-
University Hospital, Basel, SwitzerlandCompletedWater-Electrolyte Imbalance | ThirstSwitzerland
-
Brigham and Women's HospitalCharles A. King Trust Postdoctoral Fellowship ProgramNot yet recruiting
-
Indiana UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedHealthy | Type 2 Diabetes MellitusUnited States
-
Eli Lilly and CompanyRecruitingHepatic Insufficiency | HealthyUnited States
-
Karl NeffUniversity College DublinCompletedDiabetic Kidney DiseaseIreland
-
University Hospital, Basel, SwitzerlandSwiss National Science Foundation; Goldschmidt-Jacobson FoundationCompleted
-
University Hospital, Gentofte, CopenhagenCompletedType 1 Diabetes | Type 2 DiabetesDenmark
-
Johns Hopkins UniversityTerminatedBariatric SurgeryUnited States
-
Eli Lilly and CompanyCompletedType 2 DiabetesUnited States, Puerto Rico, Spain, Japan, Germany, Czechia, Poland, Slovakia
-
Third Military Medical UniversityUnknownGLP-1；Metformin；Telomere-telomerase System；Par-4China
-
University Hospital, Gentofte, CopenhagenUniversity of CopenhagenCompletedGlucose Metabolism DisordersDenmark
-
Annesofie FaurschouUniversity of CopenhagenCompleted
-
Uppsala UniversityKarolinska InstitutetCompletedFunctional Gastrointestinal DisordersSweden